ArticleFrontiers in oncology2021

Beyond BRCA Status: Clinical Biomarkers May Predict Therapeutic Effects of Olaparib in Platinum-Sensitive Ovarian Cancer Recurrence.

Kazuho Nakanishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.